SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-24-031441
Filing Date
2024-03-14
Accepted
2024-03-14 16:01:43
Documents
14
Period of Report
2024-03-14
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K life-20240314.htm   iXBRL 8-K 49008
2 EX-99.1 life-ex99_1.htm EX-99.1 156531
3 GRAPHIC img140509417_0.jpg GRAPHIC 10984
  Complete submission text file 0000950170-24-031441.txt   347838

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT life-20240314.xsd EX-101.SCH 26019
15 EXTRACTED XBRL INSTANCE DOCUMENT life-20240314_htm.xml XML 4711
Mailing Address 10240 SORRENTO VALLEY ROAD SUITE 300 SAN DIEGO CA 92121
Business Address 10240 SORRENTO VALLEY ROAD SUITE 300 SAN DIEGO CA 92121 8587318389
aTYR PHARMA INC (Filer) CIK: 0001339970 (see all company filings)

IRS No.: 203435077 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37378 | Film No.: 24749654
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)